Dendritic cell-expanded, islet-specific CD4+ CD25+ CD62L+ regulatory T cells restore normoglycemia in diabetic NOD mice

Kristin V. Tarbell, Lucine Petit, Xiaopan Zuo, Priscilla Toy, Xunrong Luo, Amina Mqadmi, Hua Yang, Manikkam Suthanthiran, Svetlana Mojsov, Ralph M. Steinman

Research output: Contribution to journalArticle

256 Citations (Scopus)

Abstract

Most treatments that prevent autoimmune diabetes in nonobese diabetic (NOD) mice require intervention at early pathogenic stages, when insulitis is first developing. We tested whether dendritic cell (DC)-expanded, islet antigen-specific CD4+ CD25+ suppressor T cells could treat diabetes at later stages of disease, when most of the insulin-producing islet β cells had been destroyed by infiltrating lymphocytes. CD4+ CD25+ CD62L+ regulatory T cells (T reg cells) from BDC2.5 T cell receptor transgenic mice were expanded with antigen-pulsed DCs and IL-2, and were then injected into NOD mice. A single dose of as few as 5 × 104 of these islet-specific T reg cells blocked diabetes development in prediabetic 13-wk-old NOD mice. The T reg cells also induced long-lasting reversal of hyperglycemia in 50% of mice in which overt diabetes had developed. Successfully treated diabetic mice had similar responses to glucose challenge compared with nondiabetic NOD mice. The successfully treated mice retained diabetogenic T cells, but also had substantially increased Foxp3+ cells in draining pancreatic lymph nodes. However, these Foxp3+ cells were derived from the recipient mice and not the injected T reg cells, suggesting a role for endogenous T reg cells in maintaining tolerance after treatment. Therefore, inoculation of DC-expanded, antigen-specific suppressor T cells has considerable efficacy in ameliorating ongoing diabetes in NOD mice. JEM

Original languageEnglish
Pages (from-to)191-201
Number of pages11
JournalJournal of Experimental Medicine
Volume204
Issue number1
DOIs
Publication statusPublished - 22 Jan 2007
Externally publishedYes

Fingerprint

Inbred NOD Mouse
Regulatory T-Lymphocytes
Dendritic Cells
T-Lymphocytes
Antigens
CD4 Antigens
T-Cell Antigen Receptor
Type 1 Diabetes Mellitus
Islets of Langerhans
Hyperglycemia
Transgenic Mice
Interleukin-2
Lymph Nodes
Lymphocytes
Insulin
Glucose

ASJC Scopus subject areas

  • Immunology and Allergy
  • Immunology

Cite this

Dendritic cell-expanded, islet-specific CD4+ CD25+ CD62L+ regulatory T cells restore normoglycemia in diabetic NOD mice. / Tarbell, Kristin V.; Petit, Lucine; Zuo, Xiaopan; Toy, Priscilla; Luo, Xunrong; Mqadmi, Amina; Yang, Hua; Suthanthiran, Manikkam; Mojsov, Svetlana; Steinman, Ralph M.

In: Journal of Experimental Medicine, Vol. 204, No. 1, 22.01.2007, p. 191-201.

Research output: Contribution to journalArticle

Tarbell, Kristin V. ; Petit, Lucine ; Zuo, Xiaopan ; Toy, Priscilla ; Luo, Xunrong ; Mqadmi, Amina ; Yang, Hua ; Suthanthiran, Manikkam ; Mojsov, Svetlana ; Steinman, Ralph M. / Dendritic cell-expanded, islet-specific CD4+ CD25+ CD62L+ regulatory T cells restore normoglycemia in diabetic NOD mice. In: Journal of Experimental Medicine. 2007 ; Vol. 204, No. 1. pp. 191-201.
@article{a163c1526913405ca953830be40c477b,
title = "Dendritic cell-expanded, islet-specific CD4+ CD25+ CD62L+ regulatory T cells restore normoglycemia in diabetic NOD mice",
abstract = "Most treatments that prevent autoimmune diabetes in nonobese diabetic (NOD) mice require intervention at early pathogenic stages, when insulitis is first developing. We tested whether dendritic cell (DC)-expanded, islet antigen-specific CD4+ CD25+ suppressor T cells could treat diabetes at later stages of disease, when most of the insulin-producing islet β cells had been destroyed by infiltrating lymphocytes. CD4+ CD25+ CD62L+ regulatory T cells (T reg cells) from BDC2.5 T cell receptor transgenic mice were expanded with antigen-pulsed DCs and IL-2, and were then injected into NOD mice. A single dose of as few as 5 × 104 of these islet-specific T reg cells blocked diabetes development in prediabetic 13-wk-old NOD mice. The T reg cells also induced long-lasting reversal of hyperglycemia in 50{\%} of mice in which overt diabetes had developed. Successfully treated diabetic mice had similar responses to glucose challenge compared with nondiabetic NOD mice. The successfully treated mice retained diabetogenic T cells, but also had substantially increased Foxp3+ cells in draining pancreatic lymph nodes. However, these Foxp3+ cells were derived from the recipient mice and not the injected T reg cells, suggesting a role for endogenous T reg cells in maintaining tolerance after treatment. Therefore, inoculation of DC-expanded, antigen-specific suppressor T cells has considerable efficacy in ameliorating ongoing diabetes in NOD mice. JEM",
author = "Tarbell, {Kristin V.} and Lucine Petit and Xiaopan Zuo and Priscilla Toy and Xunrong Luo and Amina Mqadmi and Hua Yang and Manikkam Suthanthiran and Svetlana Mojsov and Steinman, {Ralph M.}",
year = "2007",
month = "1",
day = "22",
doi = "10.1084/jem.20061631",
language = "English",
volume = "204",
pages = "191--201",
journal = "Journal of Experimental Medicine",
issn = "0022-1007",
publisher = "Rockefeller University Press",
number = "1",

}

TY - JOUR

T1 - Dendritic cell-expanded, islet-specific CD4+ CD25+ CD62L+ regulatory T cells restore normoglycemia in diabetic NOD mice

AU - Tarbell, Kristin V.

AU - Petit, Lucine

AU - Zuo, Xiaopan

AU - Toy, Priscilla

AU - Luo, Xunrong

AU - Mqadmi, Amina

AU - Yang, Hua

AU - Suthanthiran, Manikkam

AU - Mojsov, Svetlana

AU - Steinman, Ralph M.

PY - 2007/1/22

Y1 - 2007/1/22

N2 - Most treatments that prevent autoimmune diabetes in nonobese diabetic (NOD) mice require intervention at early pathogenic stages, when insulitis is first developing. We tested whether dendritic cell (DC)-expanded, islet antigen-specific CD4+ CD25+ suppressor T cells could treat diabetes at later stages of disease, when most of the insulin-producing islet β cells had been destroyed by infiltrating lymphocytes. CD4+ CD25+ CD62L+ regulatory T cells (T reg cells) from BDC2.5 T cell receptor transgenic mice were expanded with antigen-pulsed DCs and IL-2, and were then injected into NOD mice. A single dose of as few as 5 × 104 of these islet-specific T reg cells blocked diabetes development in prediabetic 13-wk-old NOD mice. The T reg cells also induced long-lasting reversal of hyperglycemia in 50% of mice in which overt diabetes had developed. Successfully treated diabetic mice had similar responses to glucose challenge compared with nondiabetic NOD mice. The successfully treated mice retained diabetogenic T cells, but also had substantially increased Foxp3+ cells in draining pancreatic lymph nodes. However, these Foxp3+ cells were derived from the recipient mice and not the injected T reg cells, suggesting a role for endogenous T reg cells in maintaining tolerance after treatment. Therefore, inoculation of DC-expanded, antigen-specific suppressor T cells has considerable efficacy in ameliorating ongoing diabetes in NOD mice. JEM

AB - Most treatments that prevent autoimmune diabetes in nonobese diabetic (NOD) mice require intervention at early pathogenic stages, when insulitis is first developing. We tested whether dendritic cell (DC)-expanded, islet antigen-specific CD4+ CD25+ suppressor T cells could treat diabetes at later stages of disease, when most of the insulin-producing islet β cells had been destroyed by infiltrating lymphocytes. CD4+ CD25+ CD62L+ regulatory T cells (T reg cells) from BDC2.5 T cell receptor transgenic mice were expanded with antigen-pulsed DCs and IL-2, and were then injected into NOD mice. A single dose of as few as 5 × 104 of these islet-specific T reg cells blocked diabetes development in prediabetic 13-wk-old NOD mice. The T reg cells also induced long-lasting reversal of hyperglycemia in 50% of mice in which overt diabetes had developed. Successfully treated diabetic mice had similar responses to glucose challenge compared with nondiabetic NOD mice. The successfully treated mice retained diabetogenic T cells, but also had substantially increased Foxp3+ cells in draining pancreatic lymph nodes. However, these Foxp3+ cells were derived from the recipient mice and not the injected T reg cells, suggesting a role for endogenous T reg cells in maintaining tolerance after treatment. Therefore, inoculation of DC-expanded, antigen-specific suppressor T cells has considerable efficacy in ameliorating ongoing diabetes in NOD mice. JEM

UR - http://www.scopus.com/inward/record.url?scp=33846410255&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33846410255&partnerID=8YFLogxK

U2 - 10.1084/jem.20061631

DO - 10.1084/jem.20061631

M3 - Article

VL - 204

SP - 191

EP - 201

JO - Journal of Experimental Medicine

JF - Journal of Experimental Medicine

SN - 0022-1007

IS - 1

ER -